LEIDEN, The Netherlands--(BUSINESS WIRE)--GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic (“IVD”).
GenScript USA Inc. – a subsidiary of GenScript Biotech Corp. headquartered in Piscataway – announced May 26 it reached an agreement with Euroimmun US Inc. – a Euroimmun subsidiary based in Mountain ...
LEIDEN, Netherlands & BILBAO, Spain--(BUSINESS WIRE)--GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading ...
PISCATAWAY, N.J., June 3, 2020 /PRNewswire/ -- GenScript Biotech Corp., the world's leading research reagent provider, announced today that the company has filed for Emergency Use Authorization (EUA) ...
PISCATAWAY, N.J., May 26, 2022 /PRNewswire/ -- GenScript USA Inc., a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading biotechnology company, has reached ...
PISCATAWAY, N.J., July 28, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, ...